...
首页> 外文期刊>Circulation journal >Documented subacute stent thrombosis within thirty days after stenting with sirolimus-eluting stent (Cypher) for acute myocardial infarction: a Japanese single center retrospective non-randomized study.
【24h】

Documented subacute stent thrombosis within thirty days after stenting with sirolimus-eluting stent (Cypher) for acute myocardial infarction: a Japanese single center retrospective non-randomized study.

机译:西罗莫司洗脱支架(Cypher)支架置入急性心肌梗死后30天内有记录的亚急性支架血栓形成:一项日本单中心回顾性非随机研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The incidence of subacute stent thrombosis (SAT) within 30 days after stenting with a sirolimus-eluting stent (Cypher) for acute myocardial infarction (AMI) was retrospectively compared to that with bare-metal stents (BMS). METHODS AND RESULTS: Among 559 lesions in 558 consecutive AMI from April 2003 to February 2006, the incidence of documented SAT after Cypher implantation (2/276 lesions, 0.72%) was almost the same as for BMS (2 cases, 0.71%). Aspirin (81-100 mg/day) plus ticlopidine (200 mg/day) were administered continuously after admission in all 4 cases. CONCLUSION: Documented SAT did not increase after stenting with Cypher for AMI under aspirin plus ticlopidine.
机译:背景:回顾性地比较了使用西罗莫司洗脱支架(Cypher)对急性心肌梗死(AMI)进行支架植入后30天内的亚急性支架血栓形成(SAT)发生率与裸金属支架(BMS)的发生率。方法与结果:2003年4月至2006年2月,在558个连续AMI中的559个病变中,Cypher植入后记录的SAT发生率(2/276个病变,占0.72%)与BMS几乎相同(2例,占0.71%)。所有4例患者入院后均连续服用阿司匹林(81-100毫克/天)和噻氯匹定(200毫克/天)。结论:在阿司匹林联合噻氯匹定下,用Cypher植入AMI后SAT的SAT值没有增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号